Confluence Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46.5M | Buy |
92,781
+2,630
| +3% | +$1.26M | 0.73% | 49 |
|
|
2026
Q1 | $44.3M | Sell |
90,151
-4,913
| -5% | -$2.67M | 0.69% | 53 |
|
|
2025
Q4 | $55.1M | Buy |
95,064
+11,841
| +14% | +$6.7M | 0.83% | 44 |
|
|
2025
Q3 | $40.4M | Sell |
83,223
-253
| -0.3% | -$118K | 0.58% | 53 |
|
|
2025
Q2 | $33.8M | Buy |
83,476
+523
| +0.6% | +$219K | 0.48% | 61 |
|
|
2025
Q1 | $41.3M | Sell |
82,953
-594
| -0.7% | -$322K | 0.59% | 53 |
|
|
2024
Q4 | $43.5M | Sell |
83,547
-1,046
| -1% | -$575K | 0.6% | 59 |
|
|
2024
Q3 | $52.3M | Sell |
84,593
-1,412
| -2% | -$836K | 0.7% | 55 |
|
|
2024
Q2 | $47.6M | Sell |
86,005
-1,198
| -1% | -$686K | 0.69% | 54 |
|
|
2024
Q1 | $50.7M | Sell |
87,203
-366
| -0.4% | -$205K | 0.68% | 55 |
|
|
2023
Q4 | $46.5M | Sell |
87,569
-1,832
| -2% | -$887K | 0.66% | 55 |
|
|
2023
Q3 | $45.3M | Sell |
89,401
-1,445
| -2% | -$770K | 0.7% | 50 |
|
|
2023
Q2 | $47.4M | Sell |
90,846
-1,870
| -2% | -$1.01M | 0.69% | 50 |
|
|
2023
Q1 | $53.4M | Sell |
92,716
-5,210
| -5% | -$2.94M | 0.79% | 47 |
|
|
2022
Q4 | $53.9M | Sell |
97,926
-1,814
| -2% | -$961K | 0.8% | 48 |
|
|
2022
Q3 | $50.6M | Sell |
99,740
-2,270
| -2% | -$1.27M | 0.84% | 49 |
|
|
2022
Q2 | $55.4M | Sell |
102,010
-457
| -0.4% | -$252K | 0.86% | 47 |
|
|
2022
Q1 | $60.5M | Sell |
102,467
-515
| -0.5% | -$296K | 0.85% | 49 |
|
|
2021
Q4 | $68.7M | Sell |
102,982
-1,223
| -1% | -$764K | 0.91% | 46 |
|
|
2021
Q3 | $59.5M | Sell |
104,205
-1,158
| -1% | -$636K | 0.84% | 48 |
|
|
2021
Q2 | $53.2M | Buy |
105,363
+535
| +0.5% | +$252K | 0.71% | 54 |
|
|
2021
Q1 | $47.8M | Buy |
104,828
+1,615
| +2% | +$771K | 0.67% | 53 |
|
|
2020
Q4 | $48.1M | Sell |
103,213
-539
| -0.5% | -$253K | 0.72% | 51 |
|
|
2020
Q3 | $45.8M | Sell |
103,752
-28,442
| -22% | -$11.8M | 0.74% | 46 |
|
|
2020
Q2 | $47.9M | Sell |
132,194
-3,049
| -2% | -$1.02M | 0.8% | 44 |
|
|
2020
Q1 | $38.4M | Sell |
135,243
-15,441
| -10% | -$4.87M | 0.73% | 44 |
|
|
2019
Q4 | $44.3M | Buy |
150,684
+1,780
| +1% | +$540K | 0.71% | 47 |
|
|
2019
Q3 | $43.4M | Sell |
148,904
-1,780
| -1% | -$510K | 0.68% | 46 |
|
|
2019
Q2 | $44.3M | Sell |
150,684
-2,447
| -2% | -$674K | 0.71% | 47 |
|
|
2019
Q1 | $41.9M | Sell |
153,131
-4,757
| -3% | -$1.18M | 0.71% | 46 |
|
|
2018
Q4 | $35.3M | Sell |
157,888
-4,166
| -3% | -$977K | 0.66% | 47 |
|
|
2018
Q3 | $39.6M | Sell |
162,054
-1,609
| -1% | -$370K | 0.67% | 46 |
|
|
2018
Q2 | $33.9M | Sell |
163,663
-4,761
| -3% | -$1.01M | 0.6% | 49 |
|
|
2018
Q1 | $34.8M | Sell |
168,424
-15,544
| -8% | -$3.26M | 0.64% | 48 |
|
|
2017
Q4 | $34.9M | Sell |
183,968
-5,792
| -3% | -$1.11M | 0.64% | 53 |
|
|
2017
Q3 | $35.9M | Sell |
189,760
-1,321
| -0.7% | -$239K | 0.69% | 50 |
|
|
2017
Q2 | $33.3M | Buy |
191,081
+7,324
| +4% | +$1.23M | 0.68% | 48 |
|
|
2017
Q1 | $28.2M | Sell |
183,757
-1,214
| -0.7% | -$186K | 0.63% | 51 |
|
|
2016
Q4 | $26.1M | Sell |
184,971
-14,281
| -7% | -$2.11M | 0.63% | 50 |
|
|
2016
Q3 | $31.7M | Buy |
199,252
+4,190
| +2% | +$646K | 0.83% | 45 |
|
|
2016
Q2 | $28.8M | Buy |
195,062
+12,334
| +7% | +$1.82M | 0.79% | 48 |
|
|
2016
Q1 | $25.9M | Buy |
182,728
+7,235
| +4% | +$970K | 0.77% | 50 |
|
|
2015
Q4 | $24.9M | Buy |
175,493
+7,927
| +5% | +$1.06M | 0.81% | 45 |
|
|
2015
Q3 | $20.5M | Buy |
167,566
+10,571
| +7% | +$1.38M | 0.75% | 49 |
|
|
2015
Q2 | $20.4M | Buy |
156,995
+8,867
| +6% | +$1.16M | 0.74% | 49 |
|
|
2015
Q1 | $19.9M | Buy |
148,128
+13,115
| +10% | +$1.69M | 0.75% | 46 |
|
|
2014
Q4 | $16.9M | Buy |
135,013
+14,825
| +12% | +$1.8M | 0.69% | 52 |
|
|
2014
Q3 | $14.6M | Buy |
120,188
+3,055
| +3% | +$371K | 0.65% | 54 |
|
|
2014
Q2 | $13.8M | Buy |
117,133
+17,636
| +18% | +$2.08M | 0.63% | 56 |
|
|
2014
Q1 | $12M | Sell |
99,497
-18,485
| -16% | -$2.2M | 0.61% | 55 |
|
|
2013
Q4 | $13.1M | Sell |
117,982
-1,612
| -1% | -$160K | 0.73% | 43 |
|
|
2013
Q3 | $11M | Buy |
119,594
+3,267
| +3% | +$295K | 0.68% | 50 |
|
|
2013
Q2 | $9.85M | Buy |
+116,327
| New | +$9.68M | 0.68% | 52 |
|
Other funds holding TMO
Confluence Investment Management's TMO Position: Q2 2026 in Review
Confluence Investment Management increased its Thermo Fisher Scientific (TMO) stake by 2.9% in Q2 2026, buying an estimated $1.26M and bringing the position to 92,781 shares worth $46.5M. The position accounts for 0.73% of the portfolio, ranked #49.
Confluence Investment Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $68.7M in Q4 2021. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Confluence Investment Management held 92,781 shares of Thermo Fisher Scientific worth $46.5M as of Q2 2026.
- Confluence Investment Management bought 2,630 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.26M.
- Thermo Fisher Scientific made up 0.73% of Confluence Investment Management's portfolio in Q2 2026, its #49 holding.
- Confluence Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Confluence Investment Management's Thermo Fisher Scientific position peaked at $68.7M in Q4 2021.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Confluence Investment Management's 13F filing for Q2 2026, filed 1 Jul 2026.